ArticleClinical immunology (Orlando, Fla.)2017

Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.

Lauren M F Merlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.